Combination significantly improved disease-free survival in phase III trial ...

AstraZeneca has fired another volley in its bladder cancer competition with Merck’s Keytruda, with the FDA on Thursday ...

A 56-year-old farmer ignored painful urination for years before doctors discovered a massive bladder stone weighing 1.3kg ...

PureHealth Research is spotlighting the vital role of clinical Lycopene and targeted botanicals in its doctor-formulated prostate support supplements. Backed by decades of peer-reviewed research, ...

Every year, about 85,000 Americans are diagnosed with bladder cancer. While treatment is often successful, bladder cancer has one of the highest rates of recurrence of any cancer: Following treatment, ...

A 40-year-old man shared how blood in his urine led to a bladder cancer diagnosis at age 39, decades before most people develop the disease. James 'Jimi' Stewart is now cancer-free after receiving a ...

When you live with overactive bladder (OAB), your overwhelming worry becomes, "Where is the nearest bathroom?" You never know when you'll feel the sudden urge to urinate -- the hallmark of urge ...

AstraZeneca’s IMFINZI ® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve ...

Whether you’re catching up with friends or soaking up the sun in your own back yard, the last thing you want to worry about ...

Bladder cancer typically develops in the lining of the bladder and is more commonly associated with symptoms such as blood in ...

56-year-old farmer tries unsuccessfully to self-medicate, stops travelling for fear of consequences, cannot sleep ...